Global Contraceptives Supply, Demand and Key Producers, 2026-2032
The global Contraceptives market size is expected to reach $ 2496 million by 2032, rising at a market growth of 2.4% CAGR during the forecast period (2026-2032).
In medical and regulatory contexts, the term 'contraceptives' refers to pharmaceutical and device systems that prevent pregnancy by inhibiting ovulation, altering the cervical mucus and endometrial environment, or blocking fertilization/implantation. The core paradigms include oral hormonal formulations, injectable progestins, intrauterine systems (copper or levonorgestrel-releasing devices), and emergency contraceptives. Their suitability for different populations, contraindications, and adherence management are continuously updated through evidence-based guidelines and labeling, such as the U.S. CDC’s 2024 'Medical Eligibility Criteria for Contraceptive Use' and the EU/UK’s risk-benefit assessments and reclassification practices for combined hormonal and progestin-only products. These serve as the policy basis and technical foundation for prescription-to-nonprescription switches, pharmacy accessibility, and self-administration.
Market Opportunities and Driving ForcesDemand-side dynamics are shaped by demographics, women's fertility intentions, and awareness of reproductive health rights. Policy-side drivers primarily include national family planning initiatives and international organizational support for accessibility. Technologically, innovation is propelled by drug molecule optimization, delivery systems, and digital health solutions (e-prescriptions, follow-ups, education), enabling new adoption scenarios. Companies recognize opportunities not only in replacing or upgrading conventional oral and barrier products but also in penetrating primary healthcare markets and youth demographics through integrated services (e.g., online consultation + offline pickup). Challenges arise from regulatory disparities, long-term safety monitoring requirements, and supply chain disruptions due to cultural or policy restrictions in certain regions. To maintain trust, enterprises must integrate rigorous clinical evidence, traceable supply chains, and collaboration with public institutions to transform opportunities into sustainable growth.Key Industry Chain: Who Captures Value?The upstream segment involves APIs, pharmaceutical excipients, CDMOs, and prescription R&D. The midstream covers formulation, medical device manufacturing, and quality control. The downstream sector is dominated by pharmacies, hospitals, family planning programs, international philanthropic procurement, and e-commerce channels. Representative multinational R&D and channel players operate across both upstream and downstream: pharmaceutical companies lead molecular innovation and registration pathways, local drugmakers and CDMOs handle scaled production, while consumer brands (e.g., condom operators) dominate end-user education and retail systems. Downstream touchpoints are diverse and sticky, making channel integration a decisive competitive advantage. Key partners include government health programs, international organizations, and local distribution networks.Growth Drivers in Sub-SectorsBy application and end-user, short-acting oral and barrier methods maintain steady demand among general prevention and first-time users. Long-acting reversible contraceptives (LARCs) and implant/intrauterine delivery systems are rising fastest among populations seeking long-term, intervention-free solutions. Digital prescription platforms and visual education services targeting adolescents and mobile populations are emerging as new growth frontiers. Meanwhile, premium differentiated products based on formulation innovations (e.g., novel estrogen molecules or milder hormonal combinations) and branded products emphasizing emotional/sexual wellness (e.g., functionalized condoms) are gaining rapid traction in consumption-upgrading markets. To succeed in sub-sectors, companies must simultaneously invest in clinical acceptability, user experience, and channel storytelling.Regional Landscape: Buyers, Producers, and TrendsettersNorth America is characterized by mature regulation, R&D-driven innovation, and insurance/prescription systems, where novel drugs and new indications are prioritized. China and Asia-Pacific exhibit a dual-track market: rapid expansion driven by massive grassroots demand and e-commerce penetration, alongside the need for localized channel innovations within specific cultural and regulatory contexts. Europe emphasizes public health procurement and high regulatory standards, prioritizing long-term safety monitoring and insurance coverage. Other regions are heavily influenced by international aid and NGO procurement, where policy or funding volatility directly impacts accessibility and supply stability. Collaboration between multinational corporations and international organizations, coupled with deep localization in distribution ecosystems, determines the implementation speed and resilience of regional markets.Latest DevelopmentsNovember 15, 2023: Bayer announced a two-year partnership with the UN Population Fund in India to expand reproductive health services for youth and couples through integrated digital and grassroots health systems?
February 29, 2024: Reuters reported that Reckitt (owner of Durex) is exploring live-streaming e-commerce in China to expand condom market share. Facing regulatory constraints on sexual content, the company adopted incremental livestreaming strategies to boost online sales?
August 6, 2025: Multiple media outlets cited NGO data highlighting the U.S. government's decision to handle donated contraceptive supplies, leading to the destruction of several batches. This raised concerns about aid supply chain risks and accessibility in recipient countries.
This report studies the global Contraceptives production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Contraceptives and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Contraceptives that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Contraceptives total production and demand, 2021-2032, (M Units)
Global Contraceptives total production value, 2021-2032, (USD Million)
Global Contraceptives production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (M Units), (based on production site)
Global Contraceptives consumption by region & country, CAGR, 2021-2032 & (M Units)
U.S. VS China: Contraceptives domestic production, consumption, key domestic manufacturers and share
Global Contraceptives production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (M Units)
Global Contraceptives production by Type, production, value, CAGR, 2021-2032, (USD Million) & (M Units)
Global Contraceptives production by End User, production, value, CAGR, 2021-2032, (USD Million) & (M Units)
This report profiles key players in the global Contraceptives market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, Pfizer, Teva, Actavis, Gedeon Richter, ZiZhu, Baijingyu, Sine, Reckitt, AbbVie, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Contraceptives market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Units) and average price (USD/Unit) by manufacturer, by Type, and by End User. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Contraceptives Market, By Region:
1. How big is the global Contraceptives market?
2. What is the demand of the global Contraceptives market?
3. What is the year over year growth of the global Contraceptives market?
4. What is the production and production value of the global Contraceptives market?
5. Who are the key producers in the global Contraceptives market?
6. What are the growth factors driving the market demand?
In medical and regulatory contexts, the term 'contraceptives' refers to pharmaceutical and device systems that prevent pregnancy by inhibiting ovulation, altering the cervical mucus and endometrial environment, or blocking fertilization/implantation. The core paradigms include oral hormonal formulations, injectable progestins, intrauterine systems (copper or levonorgestrel-releasing devices), and emergency contraceptives. Their suitability for different populations, contraindications, and adherence management are continuously updated through evidence-based guidelines and labeling, such as the U.S. CDC’s 2024 'Medical Eligibility Criteria for Contraceptive Use' and the EU/UK’s risk-benefit assessments and reclassification practices for combined hormonal and progestin-only products. These serve as the policy basis and technical foundation for prescription-to-nonprescription switches, pharmacy accessibility, and self-administration.
Market Opportunities and Driving ForcesDemand-side dynamics are shaped by demographics, women's fertility intentions, and awareness of reproductive health rights. Policy-side drivers primarily include national family planning initiatives and international organizational support for accessibility. Technologically, innovation is propelled by drug molecule optimization, delivery systems, and digital health solutions (e-prescriptions, follow-ups, education), enabling new adoption scenarios. Companies recognize opportunities not only in replacing or upgrading conventional oral and barrier products but also in penetrating primary healthcare markets and youth demographics through integrated services (e.g., online consultation + offline pickup). Challenges arise from regulatory disparities, long-term safety monitoring requirements, and supply chain disruptions due to cultural or policy restrictions in certain regions. To maintain trust, enterprises must integrate rigorous clinical evidence, traceable supply chains, and collaboration with public institutions to transform opportunities into sustainable growth.Key Industry Chain: Who Captures Value?The upstream segment involves APIs, pharmaceutical excipients, CDMOs, and prescription R&D. The midstream covers formulation, medical device manufacturing, and quality control. The downstream sector is dominated by pharmacies, hospitals, family planning programs, international philanthropic procurement, and e-commerce channels. Representative multinational R&D and channel players operate across both upstream and downstream: pharmaceutical companies lead molecular innovation and registration pathways, local drugmakers and CDMOs handle scaled production, while consumer brands (e.g., condom operators) dominate end-user education and retail systems. Downstream touchpoints are diverse and sticky, making channel integration a decisive competitive advantage. Key partners include government health programs, international organizations, and local distribution networks.Growth Drivers in Sub-SectorsBy application and end-user, short-acting oral and barrier methods maintain steady demand among general prevention and first-time users. Long-acting reversible contraceptives (LARCs) and implant/intrauterine delivery systems are rising fastest among populations seeking long-term, intervention-free solutions. Digital prescription platforms and visual education services targeting adolescents and mobile populations are emerging as new growth frontiers. Meanwhile, premium differentiated products based on formulation innovations (e.g., novel estrogen molecules or milder hormonal combinations) and branded products emphasizing emotional/sexual wellness (e.g., functionalized condoms) are gaining rapid traction in consumption-upgrading markets. To succeed in sub-sectors, companies must simultaneously invest in clinical acceptability, user experience, and channel storytelling.Regional Landscape: Buyers, Producers, and TrendsettersNorth America is characterized by mature regulation, R&D-driven innovation, and insurance/prescription systems, where novel drugs and new indications are prioritized. China and Asia-Pacific exhibit a dual-track market: rapid expansion driven by massive grassroots demand and e-commerce penetration, alongside the need for localized channel innovations within specific cultural and regulatory contexts. Europe emphasizes public health procurement and high regulatory standards, prioritizing long-term safety monitoring and insurance coverage. Other regions are heavily influenced by international aid and NGO procurement, where policy or funding volatility directly impacts accessibility and supply stability. Collaboration between multinational corporations and international organizations, coupled with deep localization in distribution ecosystems, determines the implementation speed and resilience of regional markets.Latest DevelopmentsNovember 15, 2023: Bayer announced a two-year partnership with the UN Population Fund in India to expand reproductive health services for youth and couples through integrated digital and grassroots health systems?
February 29, 2024: Reuters reported that Reckitt (owner of Durex) is exploring live-streaming e-commerce in China to expand condom market share. Facing regulatory constraints on sexual content, the company adopted incremental livestreaming strategies to boost online sales?
August 6, 2025: Multiple media outlets cited NGO data highlighting the U.S. government's decision to handle donated contraceptive supplies, leading to the destruction of several batches. This raised concerns about aid supply chain risks and accessibility in recipient countries.
This report studies the global Contraceptives production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Contraceptives and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Contraceptives that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Contraceptives total production and demand, 2021-2032, (M Units)
Global Contraceptives total production value, 2021-2032, (USD Million)
Global Contraceptives production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (M Units), (based on production site)
Global Contraceptives consumption by region & country, CAGR, 2021-2032 & (M Units)
U.S. VS China: Contraceptives domestic production, consumption, key domestic manufacturers and share
Global Contraceptives production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (M Units)
Global Contraceptives production by Type, production, value, CAGR, 2021-2032, (USD Million) & (M Units)
Global Contraceptives production by End User, production, value, CAGR, 2021-2032, (USD Million) & (M Units)
This report profiles key players in the global Contraceptives market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, Pfizer, Teva, Actavis, Gedeon Richter, ZiZhu, Baijingyu, Sine, Reckitt, AbbVie, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Contraceptives market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Units) and average price (USD/Unit) by manufacturer, by Type, and by End User. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Contraceptives Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Pills
- Injectable
- Condoms
- Vaginal Rings
- IUDs
- Subdermal Implants
- Others
- 15–24 years
- 25–34 years
- 35–44 years
- Above 44 years
- Bayer
- Pfizer
- Teva
- Actavis
- Gedeon Richter
- ZiZhu
- Baijingyu
- Sine
- Reckitt
- AbbVie
- Church & Dwight
- Cooper Companies
- TherapeuticsMD
- Afaxys
- Mithra Pharmaceuticals
1. How big is the global Contraceptives market?
2. What is the demand of the global Contraceptives market?
3. What is the year over year growth of the global Contraceptives market?
4. What is the production and production value of the global Contraceptives market?
5. Who are the key producers in the global Contraceptives market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Contraceptives Introduction
1.2 World Contraceptives Supply & Forecast
1.2.1 World Contraceptives Production Value (2021 & 2025 & 2032)
1.2.2 World Contraceptives Production (2021-2032)
1.2.3 World Contraceptives Pricing Trends (2021-2032)
1.3 World Contraceptives Production by Region (Based on Production Site)
1.3.1 World Contraceptives Production Value by Region (2021-2032)
1.3.2 World Contraceptives Production by Region (2021-2032)
1.3.3 World Contraceptives Average Price by Region (2021-2032)
1.3.4 North America Contraceptives Production (2021-2032)
1.3.5 Europe Contraceptives Production (2021-2032)
1.3.6 China Contraceptives Production (2021-2032)
1.3.7 Japan Contraceptives Production (2021-2032)
1.3.8 Israel Contraceptives Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Contraceptives Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Contraceptives Major Market Trends
2 DEMAND SUMMARY
2.1 World Contraceptives Demand (2021-2032)
2.2 World Contraceptives Consumption by Region
2.2.1 World Contraceptives Consumption by Region (2021-2026)
2.2.2 World Contraceptives Consumption Forecast by Region (2027-2032)
2.3 United States Contraceptives Consumption (2021-2032)
2.4 China Contraceptives Consumption (2021-2032)
2.5 Europe Contraceptives Consumption (2021-2032)
2.6 Japan Contraceptives Consumption (2021-2032)
2.7 South Korea Contraceptives Consumption (2021-2032)
2.8 ASEAN Contraceptives Consumption (2021-2032)
2.9 India Contraceptives Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Contraceptives Production Value by Manufacturer (2021-2026)
3.2 World Contraceptives Production by Manufacturer (2021-2026)
3.3 World Contraceptives Average Price by Manufacturer (2021-2026)
3.4 Contraceptives Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Contraceptives Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Contraceptives in 2025
3.5.3 Global Concentration Ratios (CR8) for Contraceptives in 2025
3.6 Contraceptives Market: Overall Company Footprint Analysis
3.6.1 Contraceptives Market: Region Footprint
3.6.2 Contraceptives Market: Company Product Type Footprint
3.6.3 Contraceptives Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Contraceptives Production Value Comparison
4.1.1 United States VS China: Contraceptives Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Contraceptives Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Contraceptives Production Comparison
4.2.1 United States VS China: Contraceptives Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Contraceptives Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Contraceptives Consumption Comparison
4.3.1 United States VS China: Contraceptives Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Contraceptives Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Contraceptives Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Contraceptives Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Contraceptives Production Value (2021-2026)
4.4.3 United States Based Manufacturers Contraceptives Production (2021-2026)
4.5 China Based Contraceptives Manufacturers and Market Share
4.5.1 China Based Contraceptives Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Contraceptives Production Value (2021-2026)
4.5.3 China Based Manufacturers Contraceptives Production (2021-2026)
4.6 Rest of World Based Contraceptives Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Contraceptives Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Contraceptives Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Contraceptives Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Contraceptives Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Pills
5.2.2 Injectable
5.2.3 Condoms
5.2.4 Vaginal Rings
5.2.5 IUDs
5.2.6 Subdermal Implants
5.2.7 Others
5.3 Market Segment by Type
5.3.1 World Contraceptives Production by Type (2021-2032)
5.3.2 World Contraceptives Production Value by Type (2021-2032)
5.3.3 World Contraceptives Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY END USER
6.1 World Contraceptives Market Size Overview by End User: 2021 VS 2025 VS 2032
6.2 Segment Introduction by End User
6.2.1 15–24 years
6.2.2 25–34 years
6.2.3 35–44 years
6.2.4 Above 44 years
6.3 Market Segment by End User
6.3.1 World Contraceptives Production by End User (2021-2032)
6.3.2 World Contraceptives Production Value by End User (2021-2032)
6.3.3 World Contraceptives Average Price by End User (2021-2032)
7 COMPANY PROFILES
7.1 Bayer
7.1.1 Bayer Details
7.1.2 Bayer Major Business
7.1.3 Bayer Contraceptives Product and Services
7.1.4 Bayer Contraceptives Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.1.5 Bayer Recent Developments/Updates
7.1.6 Bayer Competitive Strengths & Weaknesses
7.2 Pfizer
7.2.1 Pfizer Details
7.2.2 Pfizer Major Business
7.2.3 Pfizer Contraceptives Product and Services
7.2.4 Pfizer Contraceptives Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.2.5 Pfizer Recent Developments/Updates
7.2.6 Pfizer Competitive Strengths & Weaknesses
7.3 Teva
7.3.1 Teva Details
7.3.2 Teva Major Business
7.3.3 Teva Contraceptives Product and Services
7.3.4 Teva Contraceptives Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.3.5 Teva Recent Developments/Updates
7.3.6 Teva Competitive Strengths & Weaknesses
7.4 Actavis
7.4.1 Actavis Details
7.4.2 Actavis Major Business
7.4.3 Actavis Contraceptives Product and Services
7.4.4 Actavis Contraceptives Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.4.5 Actavis Recent Developments/Updates
7.4.6 Actavis Competitive Strengths & Weaknesses
7.5 Gedeon Richter
7.5.1 Gedeon Richter Details
7.5.2 Gedeon Richter Major Business
7.5.3 Gedeon Richter Contraceptives Product and Services
7.5.4 Gedeon Richter Contraceptives Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.5.5 Gedeon Richter Recent Developments/Updates
7.5.6 Gedeon Richter Competitive Strengths & Weaknesses
7.6 ZiZhu
7.6.1 ZiZhu Details
7.6.2 ZiZhu Major Business
7.6.3 ZiZhu Contraceptives Product and Services
7.6.4 ZiZhu Contraceptives Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.6.5 ZiZhu Recent Developments/Updates
7.6.6 ZiZhu Competitive Strengths & Weaknesses
7.7 Baijingyu
7.7.1 Baijingyu Details
7.7.2 Baijingyu Major Business
7.7.3 Baijingyu Contraceptives Product and Services
7.7.4 Baijingyu Contraceptives Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.7.5 Baijingyu Recent Developments/Updates
7.7.6 Baijingyu Competitive Strengths & Weaknesses
7.8 Sine
7.8.1 Sine Details
7.8.2 Sine Major Business
7.8.3 Sine Contraceptives Product and Services
7.8.4 Sine Contraceptives Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.8.5 Sine Recent Developments/Updates
7.8.6 Sine Competitive Strengths & Weaknesses
7.9 Reckitt
7.9.1 Reckitt Details
7.9.2 Reckitt Major Business
7.9.3 Reckitt Contraceptives Product and Services
7.9.4 Reckitt Contraceptives Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.9.5 Reckitt Recent Developments/Updates
7.9.6 Reckitt Competitive Strengths & Weaknesses
7.10 AbbVie
7.10.1 AbbVie Details
7.10.2 AbbVie Major Business
7.10.3 AbbVie Contraceptives Product and Services
7.10.4 AbbVie Contraceptives Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.10.5 AbbVie Recent Developments/Updates
7.10.6 AbbVie Competitive Strengths & Weaknesses
7.11 Church & Dwight
7.11.1 Church & Dwight Details
7.11.2 Church & Dwight Major Business
7.11.3 Church & Dwight Contraceptives Product and Services
7.11.4 Church & Dwight Contraceptives Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.11.5 Church & Dwight Recent Developments/Updates
7.11.6 Church & Dwight Competitive Strengths & Weaknesses
7.12 Cooper Companies
7.12.1 Cooper Companies Details
7.12.2 Cooper Companies Major Business
7.12.3 Cooper Companies Contraceptives Product and Services
7.12.4 Cooper Companies Contraceptives Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.12.5 Cooper Companies Recent Developments/Updates
7.12.6 Cooper Companies Competitive Strengths & Weaknesses
7.13 TherapeuticsMD
7.13.1 TherapeuticsMD Details
7.13.2 TherapeuticsMD Major Business
7.13.3 TherapeuticsMD Contraceptives Product and Services
7.13.4 TherapeuticsMD Contraceptives Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.13.5 TherapeuticsMD Recent Developments/Updates
7.13.6 TherapeuticsMD Competitive Strengths & Weaknesses
7.14 Afaxys
7.14.1 Afaxys Details
7.14.2 Afaxys Major Business
7.14.3 Afaxys Contraceptives Product and Services
7.14.4 Afaxys Contraceptives Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.14.5 Afaxys Recent Developments/Updates
7.14.6 Afaxys Competitive Strengths & Weaknesses
7.15 Mithra Pharmaceuticals
7.15.1 Mithra Pharmaceuticals Details
7.15.2 Mithra Pharmaceuticals Major Business
7.15.3 Mithra Pharmaceuticals Contraceptives Product and Services
7.15.4 Mithra Pharmaceuticals Contraceptives Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.15.5 Mithra Pharmaceuticals Recent Developments/Updates
7.15.6 Mithra Pharmaceuticals Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Contraceptives Industry Chain
8.2 Contraceptives Upstream Analysis
8.2.1 Contraceptives Core Raw Materials
8.2.2 Main Manufacturers of Contraceptives Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Contraceptives Production Mode
8.6 Contraceptives Procurement Model
8.7 Contraceptives Industry Sales Model and Sales Channels
8.7.1 Contraceptives Sales Model
8.7.2 Contraceptives Typical Distributors
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Contraceptives Introduction
1.2 World Contraceptives Supply & Forecast
1.2.1 World Contraceptives Production Value (2021 & 2025 & 2032)
1.2.2 World Contraceptives Production (2021-2032)
1.2.3 World Contraceptives Pricing Trends (2021-2032)
1.3 World Contraceptives Production by Region (Based on Production Site)
1.3.1 World Contraceptives Production Value by Region (2021-2032)
1.3.2 World Contraceptives Production by Region (2021-2032)
1.3.3 World Contraceptives Average Price by Region (2021-2032)
1.3.4 North America Contraceptives Production (2021-2032)
1.3.5 Europe Contraceptives Production (2021-2032)
1.3.6 China Contraceptives Production (2021-2032)
1.3.7 Japan Contraceptives Production (2021-2032)
1.3.8 Israel Contraceptives Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Contraceptives Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Contraceptives Major Market Trends
2 DEMAND SUMMARY
2.1 World Contraceptives Demand (2021-2032)
2.2 World Contraceptives Consumption by Region
2.2.1 World Contraceptives Consumption by Region (2021-2026)
2.2.2 World Contraceptives Consumption Forecast by Region (2027-2032)
2.3 United States Contraceptives Consumption (2021-2032)
2.4 China Contraceptives Consumption (2021-2032)
2.5 Europe Contraceptives Consumption (2021-2032)
2.6 Japan Contraceptives Consumption (2021-2032)
2.7 South Korea Contraceptives Consumption (2021-2032)
2.8 ASEAN Contraceptives Consumption (2021-2032)
2.9 India Contraceptives Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Contraceptives Production Value by Manufacturer (2021-2026)
3.2 World Contraceptives Production by Manufacturer (2021-2026)
3.3 World Contraceptives Average Price by Manufacturer (2021-2026)
3.4 Contraceptives Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Contraceptives Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Contraceptives in 2025
3.5.3 Global Concentration Ratios (CR8) for Contraceptives in 2025
3.6 Contraceptives Market: Overall Company Footprint Analysis
3.6.1 Contraceptives Market: Region Footprint
3.6.2 Contraceptives Market: Company Product Type Footprint
3.6.3 Contraceptives Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Contraceptives Production Value Comparison
4.1.1 United States VS China: Contraceptives Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Contraceptives Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Contraceptives Production Comparison
4.2.1 United States VS China: Contraceptives Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Contraceptives Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Contraceptives Consumption Comparison
4.3.1 United States VS China: Contraceptives Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Contraceptives Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Contraceptives Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Contraceptives Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Contraceptives Production Value (2021-2026)
4.4.3 United States Based Manufacturers Contraceptives Production (2021-2026)
4.5 China Based Contraceptives Manufacturers and Market Share
4.5.1 China Based Contraceptives Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Contraceptives Production Value (2021-2026)
4.5.3 China Based Manufacturers Contraceptives Production (2021-2026)
4.6 Rest of World Based Contraceptives Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Contraceptives Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Contraceptives Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Contraceptives Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Contraceptives Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Pills
5.2.2 Injectable
5.2.3 Condoms
5.2.4 Vaginal Rings
5.2.5 IUDs
5.2.6 Subdermal Implants
5.2.7 Others
5.3 Market Segment by Type
5.3.1 World Contraceptives Production by Type (2021-2032)
5.3.2 World Contraceptives Production Value by Type (2021-2032)
5.3.3 World Contraceptives Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY END USER
6.1 World Contraceptives Market Size Overview by End User: 2021 VS 2025 VS 2032
6.2 Segment Introduction by End User
6.2.1 15–24 years
6.2.2 25–34 years
6.2.3 35–44 years
6.2.4 Above 44 years
6.3 Market Segment by End User
6.3.1 World Contraceptives Production by End User (2021-2032)
6.3.2 World Contraceptives Production Value by End User (2021-2032)
6.3.3 World Contraceptives Average Price by End User (2021-2032)
7 COMPANY PROFILES
7.1 Bayer
7.1.1 Bayer Details
7.1.2 Bayer Major Business
7.1.3 Bayer Contraceptives Product and Services
7.1.4 Bayer Contraceptives Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.1.5 Bayer Recent Developments/Updates
7.1.6 Bayer Competitive Strengths & Weaknesses
7.2 Pfizer
7.2.1 Pfizer Details
7.2.2 Pfizer Major Business
7.2.3 Pfizer Contraceptives Product and Services
7.2.4 Pfizer Contraceptives Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.2.5 Pfizer Recent Developments/Updates
7.2.6 Pfizer Competitive Strengths & Weaknesses
7.3 Teva
7.3.1 Teva Details
7.3.2 Teva Major Business
7.3.3 Teva Contraceptives Product and Services
7.3.4 Teva Contraceptives Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.3.5 Teva Recent Developments/Updates
7.3.6 Teva Competitive Strengths & Weaknesses
7.4 Actavis
7.4.1 Actavis Details
7.4.2 Actavis Major Business
7.4.3 Actavis Contraceptives Product and Services
7.4.4 Actavis Contraceptives Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.4.5 Actavis Recent Developments/Updates
7.4.6 Actavis Competitive Strengths & Weaknesses
7.5 Gedeon Richter
7.5.1 Gedeon Richter Details
7.5.2 Gedeon Richter Major Business
7.5.3 Gedeon Richter Contraceptives Product and Services
7.5.4 Gedeon Richter Contraceptives Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.5.5 Gedeon Richter Recent Developments/Updates
7.5.6 Gedeon Richter Competitive Strengths & Weaknesses
7.6 ZiZhu
7.6.1 ZiZhu Details
7.6.2 ZiZhu Major Business
7.6.3 ZiZhu Contraceptives Product and Services
7.6.4 ZiZhu Contraceptives Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.6.5 ZiZhu Recent Developments/Updates
7.6.6 ZiZhu Competitive Strengths & Weaknesses
7.7 Baijingyu
7.7.1 Baijingyu Details
7.7.2 Baijingyu Major Business
7.7.3 Baijingyu Contraceptives Product and Services
7.7.4 Baijingyu Contraceptives Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.7.5 Baijingyu Recent Developments/Updates
7.7.6 Baijingyu Competitive Strengths & Weaknesses
7.8 Sine
7.8.1 Sine Details
7.8.2 Sine Major Business
7.8.3 Sine Contraceptives Product and Services
7.8.4 Sine Contraceptives Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.8.5 Sine Recent Developments/Updates
7.8.6 Sine Competitive Strengths & Weaknesses
7.9 Reckitt
7.9.1 Reckitt Details
7.9.2 Reckitt Major Business
7.9.3 Reckitt Contraceptives Product and Services
7.9.4 Reckitt Contraceptives Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.9.5 Reckitt Recent Developments/Updates
7.9.6 Reckitt Competitive Strengths & Weaknesses
7.10 AbbVie
7.10.1 AbbVie Details
7.10.2 AbbVie Major Business
7.10.3 AbbVie Contraceptives Product and Services
7.10.4 AbbVie Contraceptives Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.10.5 AbbVie Recent Developments/Updates
7.10.6 AbbVie Competitive Strengths & Weaknesses
7.11 Church & Dwight
7.11.1 Church & Dwight Details
7.11.2 Church & Dwight Major Business
7.11.3 Church & Dwight Contraceptives Product and Services
7.11.4 Church & Dwight Contraceptives Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.11.5 Church & Dwight Recent Developments/Updates
7.11.6 Church & Dwight Competitive Strengths & Weaknesses
7.12 Cooper Companies
7.12.1 Cooper Companies Details
7.12.2 Cooper Companies Major Business
7.12.3 Cooper Companies Contraceptives Product and Services
7.12.4 Cooper Companies Contraceptives Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.12.5 Cooper Companies Recent Developments/Updates
7.12.6 Cooper Companies Competitive Strengths & Weaknesses
7.13 TherapeuticsMD
7.13.1 TherapeuticsMD Details
7.13.2 TherapeuticsMD Major Business
7.13.3 TherapeuticsMD Contraceptives Product and Services
7.13.4 TherapeuticsMD Contraceptives Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.13.5 TherapeuticsMD Recent Developments/Updates
7.13.6 TherapeuticsMD Competitive Strengths & Weaknesses
7.14 Afaxys
7.14.1 Afaxys Details
7.14.2 Afaxys Major Business
7.14.3 Afaxys Contraceptives Product and Services
7.14.4 Afaxys Contraceptives Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.14.5 Afaxys Recent Developments/Updates
7.14.6 Afaxys Competitive Strengths & Weaknesses
7.15 Mithra Pharmaceuticals
7.15.1 Mithra Pharmaceuticals Details
7.15.2 Mithra Pharmaceuticals Major Business
7.15.3 Mithra Pharmaceuticals Contraceptives Product and Services
7.15.4 Mithra Pharmaceuticals Contraceptives Production, Price, Value, Gross Margin and Market Share (2021-2026)
7.15.5 Mithra Pharmaceuticals Recent Developments/Updates
7.15.6 Mithra Pharmaceuticals Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Contraceptives Industry Chain
8.2 Contraceptives Upstream Analysis
8.2.1 Contraceptives Core Raw Materials
8.2.2 Main Manufacturers of Contraceptives Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Contraceptives Production Mode
8.6 Contraceptives Procurement Model
8.7 Contraceptives Industry Sales Model and Sales Channels
8.7.1 Contraceptives Sales Model
8.7.2 Contraceptives Typical Distributors
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Contraceptives Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Contraceptives Production Value by Region (2021-2026) & (USD Million)
Table 3. World Contraceptives Production Value by Region (2027-2032) & (USD Million)
Table 4. World Contraceptives Production Value Market Share by Region (2021-2026)
Table 5. World Contraceptives Production Value Market Share by Region (2027-2032)
Table 6. World Contraceptives Production by Region (2021-2026) & (M Units)
Table 7. World Contraceptives Production by Region (2027-2032) & (M Units)
Table 8. World Contraceptives Production Market Share by Region (2021-2026)
Table 9. World Contraceptives Production Market Share by Region (2027-2032)
Table 10. World Contraceptives Average Price by Region (2021-2026) & (USD/Unit)
Table 11. World Contraceptives Average Price by Region (2027-2032) & (USD/Unit)
Table 12. Contraceptives Major Market Trends
Table 13. World Contraceptives Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (M Units)
Table 14. World Contraceptives Consumption by Region (2021-2026) & (M Units)
Table 15. World Contraceptives Consumption Forecast by Region (2027-2032) & (M Units)
Table 16. World Contraceptives Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Contraceptives Producers in 2025
Table 18. World Contraceptives Production by Manufacturer (2021-2026) & (M Units)
Table 19. Production Market Share of Key Contraceptives Producers in 2025
Table 20. World Contraceptives Average Price by Manufacturer (2021-2026) & (USD/Unit)
Table 21. Global Contraceptives Company Evaluation Quadrant
Table 22. World Contraceptives Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Contraceptives Production Site of Key Manufacturer
Table 24. Contraceptives Market: Company Product Type Footprint
Table 25. Contraceptives Market: Company Product Application Footprint
Table 26. Contraceptives Competitive Factors
Table 27. Contraceptives New Entrant and Capacity Expansion Plans
Table 28. Contraceptives Mergers & Acquisitions Activity
Table 29. United States VS China Contraceptives Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Contraceptives Production Comparison, (2021 & 2025 & 2032) & (M Units)
Table 31. United States VS China Contraceptives Consumption Comparison, (2021 & 2025 & 2032) & (M Units)
Table 32. United States Based Contraceptives Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Contraceptives Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Contraceptives Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Contraceptives Production (2021-2026) & (M Units)
Table 36. United States Based Manufacturers Contraceptives Production Market Share (2021-2026)
Table 37. China Based Contraceptives Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Contraceptives Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Contraceptives Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Contraceptives Production, (2021-2026) & (M Units)
Table 41. China Based Manufacturers Contraceptives Production Market Share (2021-2026)
Table 42. Rest of World Based Contraceptives Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Contraceptives Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Contraceptives Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Contraceptives Production, (2021-2026) & (M Units)
Table 46. Rest of World Based Manufacturers Contraceptives Production Market Share (2021-2026)
Table 47. World Contraceptives Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Contraceptives Production by Type (2021-2026) & (M Units)
Table 49. World Contraceptives Production by Type (2027-2032) & (M Units)
Table 50. World Contraceptives Production Value by Type (2021-2026) & (USD Million)
Table 51. World Contraceptives Production Value by Type (2027-2032) & (USD Million)
Table 52. World Contraceptives Average Price by Type (2021-2026) & (USD/Unit)
Table 53. World Contraceptives Average Price by Type (2027-2032) & (USD/Unit)
Table 54. World Contraceptives Production Value by End User, (USD Million), 2021 & 2025 & 2032
Table 55. World Contraceptives Production by End User (2021-2026) & (M Units)
Table 56. World Contraceptives Production by End User (2027-2032) & (M Units)
Table 57. World Contraceptives Production Value by End User (2021-2026) & (USD Million)
Table 58. World Contraceptives Production Value by End User (2027-2032) & (USD Million)
Table 59. World Contraceptives Average Price by End User (2021-2026) & (USD/Unit)
Table 60. World Contraceptives Average Price by End User (2027-2032) & (USD/Unit)
Table 61. Bayer Basic Information, Manufacturing Base and Competitors
Table 62. Bayer Major Business
Table 63. Bayer Contraceptives Product and Services
Table 64. Bayer Contraceptives Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Bayer Recent Developments/Updates
Table 66. Bayer Competitive Strengths & Weaknesses
Table 67. Pfizer Basic Information, Manufacturing Base and Competitors
Table 68. Pfizer Major Business
Table 69. Pfizer Contraceptives Product and Services
Table 70. Pfizer Contraceptives Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 71. Pfizer Recent Developments/Updates
Table 72. Pfizer Competitive Strengths & Weaknesses
Table 73. Teva Basic Information, Manufacturing Base and Competitors
Table 74. Teva Major Business
Table 75. Teva Contraceptives Product and Services
Table 76. Teva Contraceptives Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. Teva Recent Developments/Updates
Table 78. Teva Competitive Strengths & Weaknesses
Table 79. Actavis Basic Information, Manufacturing Base and Competitors
Table 80. Actavis Major Business
Table 81. Actavis Contraceptives Product and Services
Table 82. Actavis Contraceptives Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 83. Actavis Recent Developments/Updates
Table 84. Actavis Competitive Strengths & Weaknesses
Table 85. Gedeon Richter Basic Information, Manufacturing Base and Competitors
Table 86. Gedeon Richter Major Business
Table 87. Gedeon Richter Contraceptives Product and Services
Table 88. Gedeon Richter Contraceptives Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Gedeon Richter Recent Developments/Updates
Table 90. Gedeon Richter Competitive Strengths & Weaknesses
Table 91. ZiZhu Basic Information, Manufacturing Base and Competitors
Table 92. ZiZhu Major Business
Table 93. ZiZhu Contraceptives Product and Services
Table 94. ZiZhu Contraceptives Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. ZiZhu Recent Developments/Updates
Table 96. ZiZhu Competitive Strengths & Weaknesses
Table 97. Baijingyu Basic Information, Manufacturing Base and Competitors
Table 98. Baijingyu Major Business
Table 99. Baijingyu Contraceptives Product and Services
Table 100. Baijingyu Contraceptives Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 101. Baijingyu Recent Developments/Updates
Table 102. Baijingyu Competitive Strengths & Weaknesses
Table 103. Sine Basic Information, Manufacturing Base and Competitors
Table 104. Sine Major Business
Table 105. Sine Contraceptives Product and Services
Table 106. Sine Contraceptives Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 107. Sine Recent Developments/Updates
Table 108. Sine Competitive Strengths & Weaknesses
Table 109. Reckitt Basic Information, Manufacturing Base and Competitors
Table 110. Reckitt Major Business
Table 111. Reckitt Contraceptives Product and Services
Table 112. Reckitt Contraceptives Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 113. Reckitt Recent Developments/Updates
Table 114. Reckitt Competitive Strengths & Weaknesses
Table 115. AbbVie Basic Information, Manufacturing Base and Competitors
Table 116. AbbVie Major Business
Table 117. AbbVie Contraceptives Product and Services
Table 118. AbbVie Contraceptives Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 119. AbbVie Recent Developments/Updates
Table 120. AbbVie Competitive Strengths & Weaknesses
Table 121. Church & Dwight Basic Information, Manufacturing Base and Competitors
Table 122. Church & Dwight Major Business
Table 123. Church & Dwight Contraceptives Product and Services
Table 124. Church & Dwight Contraceptives Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. Church & Dwight Recent Developments/Updates
Table 126. Church & Dwight Competitive Strengths & Weaknesses
Table 127. Cooper Companies Basic Information, Manufacturing Base and Competitors
Table 128. Cooper Companies Major Business
Table 129. Cooper Companies Contraceptives Product and Services
Table 130. Cooper Companies Contraceptives Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 131. Cooper Companies Recent Developments/Updates
Table 132. Cooper Companies Competitive Strengths & Weaknesses
Table 133. TherapeuticsMD Basic Information, Manufacturing Base and Competitors
Table 134. TherapeuticsMD Major Business
Table 135. TherapeuticsMD Contraceptives Product and Services
Table 136. TherapeuticsMD Contraceptives Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 137. TherapeuticsMD Recent Developments/Updates
Table 138. TherapeuticsMD Competitive Strengths & Weaknesses
Table 139. Afaxys Basic Information, Manufacturing Base and Competitors
Table 140. Afaxys Major Business
Table 141. Afaxys Contraceptives Product and Services
Table 142. Afaxys Contraceptives Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 143. Afaxys Recent Developments/Updates
Table 144. Afaxys Competitive Strengths & Weaknesses
Table 145. Mithra Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 146. Mithra Pharmaceuticals Major Business
Table 147. Mithra Pharmaceuticals Contraceptives Product and Services
Table 148. Mithra Pharmaceuticals Contraceptives Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 149. Mithra Pharmaceuticals Recent Developments/Updates
Table 150. Mithra Pharmaceuticals Competitive Strengths & Weaknesses
Table 151. Global Key Players of Contraceptives Upstream (Raw Materials)
Table 152. Global Contraceptives Typical Customers
Table 153. Contraceptives Typical Distributors
Table 1. World Contraceptives Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Contraceptives Production Value by Region (2021-2026) & (USD Million)
Table 3. World Contraceptives Production Value by Region (2027-2032) & (USD Million)
Table 4. World Contraceptives Production Value Market Share by Region (2021-2026)
Table 5. World Contraceptives Production Value Market Share by Region (2027-2032)
Table 6. World Contraceptives Production by Region (2021-2026) & (M Units)
Table 7. World Contraceptives Production by Region (2027-2032) & (M Units)
Table 8. World Contraceptives Production Market Share by Region (2021-2026)
Table 9. World Contraceptives Production Market Share by Region (2027-2032)
Table 10. World Contraceptives Average Price by Region (2021-2026) & (USD/Unit)
Table 11. World Contraceptives Average Price by Region (2027-2032) & (USD/Unit)
Table 12. Contraceptives Major Market Trends
Table 13. World Contraceptives Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (M Units)
Table 14. World Contraceptives Consumption by Region (2021-2026) & (M Units)
Table 15. World Contraceptives Consumption Forecast by Region (2027-2032) & (M Units)
Table 16. World Contraceptives Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Contraceptives Producers in 2025
Table 18. World Contraceptives Production by Manufacturer (2021-2026) & (M Units)
Table 19. Production Market Share of Key Contraceptives Producers in 2025
Table 20. World Contraceptives Average Price by Manufacturer (2021-2026) & (USD/Unit)
Table 21. Global Contraceptives Company Evaluation Quadrant
Table 22. World Contraceptives Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Contraceptives Production Site of Key Manufacturer
Table 24. Contraceptives Market: Company Product Type Footprint
Table 25. Contraceptives Market: Company Product Application Footprint
Table 26. Contraceptives Competitive Factors
Table 27. Contraceptives New Entrant and Capacity Expansion Plans
Table 28. Contraceptives Mergers & Acquisitions Activity
Table 29. United States VS China Contraceptives Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Contraceptives Production Comparison, (2021 & 2025 & 2032) & (M Units)
Table 31. United States VS China Contraceptives Consumption Comparison, (2021 & 2025 & 2032) & (M Units)
Table 32. United States Based Contraceptives Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Contraceptives Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Contraceptives Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Contraceptives Production (2021-2026) & (M Units)
Table 36. United States Based Manufacturers Contraceptives Production Market Share (2021-2026)
Table 37. China Based Contraceptives Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Contraceptives Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Contraceptives Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Contraceptives Production, (2021-2026) & (M Units)
Table 41. China Based Manufacturers Contraceptives Production Market Share (2021-2026)
Table 42. Rest of World Based Contraceptives Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Contraceptives Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Contraceptives Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Contraceptives Production, (2021-2026) & (M Units)
Table 46. Rest of World Based Manufacturers Contraceptives Production Market Share (2021-2026)
Table 47. World Contraceptives Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Contraceptives Production by Type (2021-2026) & (M Units)
Table 49. World Contraceptives Production by Type (2027-2032) & (M Units)
Table 50. World Contraceptives Production Value by Type (2021-2026) & (USD Million)
Table 51. World Contraceptives Production Value by Type (2027-2032) & (USD Million)
Table 52. World Contraceptives Average Price by Type (2021-2026) & (USD/Unit)
Table 53. World Contraceptives Average Price by Type (2027-2032) & (USD/Unit)
Table 54. World Contraceptives Production Value by End User, (USD Million), 2021 & 2025 & 2032
Table 55. World Contraceptives Production by End User (2021-2026) & (M Units)
Table 56. World Contraceptives Production by End User (2027-2032) & (M Units)
Table 57. World Contraceptives Production Value by End User (2021-2026) & (USD Million)
Table 58. World Contraceptives Production Value by End User (2027-2032) & (USD Million)
Table 59. World Contraceptives Average Price by End User (2021-2026) & (USD/Unit)
Table 60. World Contraceptives Average Price by End User (2027-2032) & (USD/Unit)
Table 61. Bayer Basic Information, Manufacturing Base and Competitors
Table 62. Bayer Major Business
Table 63. Bayer Contraceptives Product and Services
Table 64. Bayer Contraceptives Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Bayer Recent Developments/Updates
Table 66. Bayer Competitive Strengths & Weaknesses
Table 67. Pfizer Basic Information, Manufacturing Base and Competitors
Table 68. Pfizer Major Business
Table 69. Pfizer Contraceptives Product and Services
Table 70. Pfizer Contraceptives Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 71. Pfizer Recent Developments/Updates
Table 72. Pfizer Competitive Strengths & Weaknesses
Table 73. Teva Basic Information, Manufacturing Base and Competitors
Table 74. Teva Major Business
Table 75. Teva Contraceptives Product and Services
Table 76. Teva Contraceptives Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 77. Teva Recent Developments/Updates
Table 78. Teva Competitive Strengths & Weaknesses
Table 79. Actavis Basic Information, Manufacturing Base and Competitors
Table 80. Actavis Major Business
Table 81. Actavis Contraceptives Product and Services
Table 82. Actavis Contraceptives Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 83. Actavis Recent Developments/Updates
Table 84. Actavis Competitive Strengths & Weaknesses
Table 85. Gedeon Richter Basic Information, Manufacturing Base and Competitors
Table 86. Gedeon Richter Major Business
Table 87. Gedeon Richter Contraceptives Product and Services
Table 88. Gedeon Richter Contraceptives Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Gedeon Richter Recent Developments/Updates
Table 90. Gedeon Richter Competitive Strengths & Weaknesses
Table 91. ZiZhu Basic Information, Manufacturing Base and Competitors
Table 92. ZiZhu Major Business
Table 93. ZiZhu Contraceptives Product and Services
Table 94. ZiZhu Contraceptives Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. ZiZhu Recent Developments/Updates
Table 96. ZiZhu Competitive Strengths & Weaknesses
Table 97. Baijingyu Basic Information, Manufacturing Base and Competitors
Table 98. Baijingyu Major Business
Table 99. Baijingyu Contraceptives Product and Services
Table 100. Baijingyu Contraceptives Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 101. Baijingyu Recent Developments/Updates
Table 102. Baijingyu Competitive Strengths & Weaknesses
Table 103. Sine Basic Information, Manufacturing Base and Competitors
Table 104. Sine Major Business
Table 105. Sine Contraceptives Product and Services
Table 106. Sine Contraceptives Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 107. Sine Recent Developments/Updates
Table 108. Sine Competitive Strengths & Weaknesses
Table 109. Reckitt Basic Information, Manufacturing Base and Competitors
Table 110. Reckitt Major Business
Table 111. Reckitt Contraceptives Product and Services
Table 112. Reckitt Contraceptives Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 113. Reckitt Recent Developments/Updates
Table 114. Reckitt Competitive Strengths & Weaknesses
Table 115. AbbVie Basic Information, Manufacturing Base and Competitors
Table 116. AbbVie Major Business
Table 117. AbbVie Contraceptives Product and Services
Table 118. AbbVie Contraceptives Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 119. AbbVie Recent Developments/Updates
Table 120. AbbVie Competitive Strengths & Weaknesses
Table 121. Church & Dwight Basic Information, Manufacturing Base and Competitors
Table 122. Church & Dwight Major Business
Table 123. Church & Dwight Contraceptives Product and Services
Table 124. Church & Dwight Contraceptives Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. Church & Dwight Recent Developments/Updates
Table 126. Church & Dwight Competitive Strengths & Weaknesses
Table 127. Cooper Companies Basic Information, Manufacturing Base and Competitors
Table 128. Cooper Companies Major Business
Table 129. Cooper Companies Contraceptives Product and Services
Table 130. Cooper Companies Contraceptives Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 131. Cooper Companies Recent Developments/Updates
Table 132. Cooper Companies Competitive Strengths & Weaknesses
Table 133. TherapeuticsMD Basic Information, Manufacturing Base and Competitors
Table 134. TherapeuticsMD Major Business
Table 135. TherapeuticsMD Contraceptives Product and Services
Table 136. TherapeuticsMD Contraceptives Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 137. TherapeuticsMD Recent Developments/Updates
Table 138. TherapeuticsMD Competitive Strengths & Weaknesses
Table 139. Afaxys Basic Information, Manufacturing Base and Competitors
Table 140. Afaxys Major Business
Table 141. Afaxys Contraceptives Product and Services
Table 142. Afaxys Contraceptives Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 143. Afaxys Recent Developments/Updates
Table 144. Afaxys Competitive Strengths & Weaknesses
Table 145. Mithra Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 146. Mithra Pharmaceuticals Major Business
Table 147. Mithra Pharmaceuticals Contraceptives Product and Services
Table 148. Mithra Pharmaceuticals Contraceptives Production (M Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 149. Mithra Pharmaceuticals Recent Developments/Updates
Table 150. Mithra Pharmaceuticals Competitive Strengths & Weaknesses
Table 151. Global Key Players of Contraceptives Upstream (Raw Materials)
Table 152. Global Contraceptives Typical Customers
Table 153. Contraceptives Typical Distributors
LIST OF FIGURES
Figure 1. Contraceptives Picture
Figure 2. World Contraceptives Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Contraceptives Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Contraceptives Production (2021-2032) & (M Units)
Figure 5. World Contraceptives Average Price (2021-2032) & (USD/Unit)
Figure 6. World Contraceptives Production Value Market Share by Region (2021-2032)
Figure 7. World Contraceptives Production Market Share by Region (2021-2032)
Figure 8. North America Contraceptives Production (2021-2032) & (M Units)
Figure 9. Europe Contraceptives Production (2021-2032) & (M Units)
Figure 10. China Contraceptives Production (2021-2032) & (M Units)
Figure 11. Japan Contraceptives Production (2021-2032) & (M Units)
Figure 12. Israel Contraceptives Production (2021-2032) & (M Units)
Figure 13. Contraceptives Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Contraceptives Consumption (2021-2032) & (M Units)
Figure 16. World Contraceptives Consumption Market Share by Region (2021-2032)
Figure 17. United States Contraceptives Consumption (2021-2032) & (M Units)
Figure 18. China Contraceptives Consumption (2021-2032) & (M Units)
Figure 19. Europe Contraceptives Consumption (2021-2032) & (M Units)
Figure 20. Japan Contraceptives Consumption (2021-2032) & (M Units)
Figure 21. South Korea Contraceptives Consumption (2021-2032) & (M Units)
Figure 22. ASEAN Contraceptives Consumption (2021-2032) & (M Units)
Figure 23. India Contraceptives Consumption (2021-2032) & (M Units)
Figure 24. Producer Shipments of Contraceptives by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Contraceptives Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Contraceptives Markets in 2025
Figure 27. United States VS China: Contraceptives Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Contraceptives Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Contraceptives Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Contraceptives Production Market Share 2025
Figure 31. China Based Manufacturers Contraceptives Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Contraceptives Production Market Share 2025
Figure 33. World Contraceptives Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Contraceptives Production Value Market Share by Type in 2025
Figure 35. Pills
Figure 36. Injectable
Figure 37. Condoms
Figure 38. Vaginal Rings
Figure 39. IUDs
Figure 40. Subdermal Implants
Figure 41. Others
Figure 42. Others
Figure 43. World Contraceptives Production Market Share by Type (2021-2032)
Figure 44. World Contraceptives Production Value Market Share by Type (2021-2032)
Figure 45. World Contraceptives Average Price by Type (2021-2032) & (USD/Unit)
Figure 46. World Contraceptives Production Value by End User, (USD Million), 2021 & 2025 & 2032
Figure 47. World Contraceptives Production Value Market Share by End User in 2025
Figure 48. 15–24 years
Figure 49. 25–34 years
Figure 50. 35–44 years
Figure 51. Above 44 years
Figure 52. World Contraceptives Production Market Share by End User (2021-2032)
Figure 53. World Contraceptives Production Value Market Share by End User (2021-2032)
Figure 54. World Contraceptives Average Price by End User (2021-2032) & (USD/Unit)
Figure 55. Contraceptives Industry Chain
Figure 56. Contraceptives Procurement Model
Figure 57. Contraceptives Sales Model
Figure 58. Contraceptives Sales Channels, Direct Sales, and Distribution
Figure 59. Methodology
Figure 60. Research Process and Data Source
Figure 1. Contraceptives Picture
Figure 2. World Contraceptives Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Contraceptives Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Contraceptives Production (2021-2032) & (M Units)
Figure 5. World Contraceptives Average Price (2021-2032) & (USD/Unit)
Figure 6. World Contraceptives Production Value Market Share by Region (2021-2032)
Figure 7. World Contraceptives Production Market Share by Region (2021-2032)
Figure 8. North America Contraceptives Production (2021-2032) & (M Units)
Figure 9. Europe Contraceptives Production (2021-2032) & (M Units)
Figure 10. China Contraceptives Production (2021-2032) & (M Units)
Figure 11. Japan Contraceptives Production (2021-2032) & (M Units)
Figure 12. Israel Contraceptives Production (2021-2032) & (M Units)
Figure 13. Contraceptives Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Contraceptives Consumption (2021-2032) & (M Units)
Figure 16. World Contraceptives Consumption Market Share by Region (2021-2032)
Figure 17. United States Contraceptives Consumption (2021-2032) & (M Units)
Figure 18. China Contraceptives Consumption (2021-2032) & (M Units)
Figure 19. Europe Contraceptives Consumption (2021-2032) & (M Units)
Figure 20. Japan Contraceptives Consumption (2021-2032) & (M Units)
Figure 21. South Korea Contraceptives Consumption (2021-2032) & (M Units)
Figure 22. ASEAN Contraceptives Consumption (2021-2032) & (M Units)
Figure 23. India Contraceptives Consumption (2021-2032) & (M Units)
Figure 24. Producer Shipments of Contraceptives by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Contraceptives Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Contraceptives Markets in 2025
Figure 27. United States VS China: Contraceptives Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Contraceptives Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Contraceptives Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Contraceptives Production Market Share 2025
Figure 31. China Based Manufacturers Contraceptives Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Contraceptives Production Market Share 2025
Figure 33. World Contraceptives Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Contraceptives Production Value Market Share by Type in 2025
Figure 35. Pills
Figure 36. Injectable
Figure 37. Condoms
Figure 38. Vaginal Rings
Figure 39. IUDs
Figure 40. Subdermal Implants
Figure 41. Others
Figure 42. Others
Figure 43. World Contraceptives Production Market Share by Type (2021-2032)
Figure 44. World Contraceptives Production Value Market Share by Type (2021-2032)
Figure 45. World Contraceptives Average Price by Type (2021-2032) & (USD/Unit)
Figure 46. World Contraceptives Production Value by End User, (USD Million), 2021 & 2025 & 2032
Figure 47. World Contraceptives Production Value Market Share by End User in 2025
Figure 48. 15–24 years
Figure 49. 25–34 years
Figure 50. 35–44 years
Figure 51. Above 44 years
Figure 52. World Contraceptives Production Market Share by End User (2021-2032)
Figure 53. World Contraceptives Production Value Market Share by End User (2021-2032)
Figure 54. World Contraceptives Average Price by End User (2021-2032) & (USD/Unit)
Figure 55. Contraceptives Industry Chain
Figure 56. Contraceptives Procurement Model
Figure 57. Contraceptives Sales Model
Figure 58. Contraceptives Sales Channels, Direct Sales, and Distribution
Figure 59. Methodology
Figure 60. Research Process and Data Source
